SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950115-00-000684
Filing Date
2000-05-12
Accepted
2000-05-12 00:00:00
Documents
5

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A SC 13D/A 37714
2 STOCK PURCHASE AGREEMENT EX-8 153013
3 REGISTRATION RIGHTS AGREEMENT EX-10 75074
4 AMENDMENT NO. 1 TO STOCKHOLDERS' AGREEMENT EX-11 10071
5 AMENDMENT TO RESTATED REGISTRATION RIGHTS AGREE. EX-12 7930
  Complete submission text file 0000950115-00-000684.txt   286449
Mailing Address CASTOR & KENSINGTON AVENUES PHILADELPHIA PA 19124-5694
Business Address CASTOR & KENSINGTON AVES PHILADELPHIA PA 19124-5694 2152892220
IMPAX LABORATORIES INC (Filed by) CIK: 0001003642 (see all company filings)

IRS No.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address CASTOR & KENSINGTON AVENUES PHILADELPHIA PA 19124-5694
Business Address CASTOR & KENSINGTON AVES PHILADELPHIA PA 19124-5694 2152892220
IMPAX LABORATORIES INC (Subject) CIK: 0001003642 (see all company filings)

IRS No.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-48867 | Film No.: 628541
SIC: 2834 Pharmaceutical Preparations